2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Hydatidiform Mole: new trials by email Literature Review of Hydatidiform Mole trials Research Report on Hydatidiform Mole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors Laboratory Biomarker Analysis, Therapeutic Conventional Surgery - Complete Hydatidiform Mole, Non-Metastatic Gestational Trophoblastic Tumor | Phase 2 | Completed | Gynecologic Oncology Group | 64 | 2007-10-09 | 2017-08-24 |
| A Trial for Patients With Gestational Trophoblastic Disease Pemetrexed - Trophoblastic Neoplasms, Uterine Neoplasms | Phase 2 | Completed | Eli Lilly and Company | 50 | 2006-07-01 | 2007-08-09 |
Choriocarcinoma (1) · Trophoblastic Neoplasms (1) · Uterine Neoplasms (1)
Female Urogenital Diseases and Pregnancy Complications (2) · Gestational Trophoblastic Disease (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Germ Cell and Embryonal (2) · Pregnancy Complications (2) · Pregnancy Complications, Neoplastic (2) · Urogenital Diseases (2) · Adenocarcinoma (1) · Carcinoma (1) · Female Urogenital Diseases (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Neoplasms by Site (1)
Pemetrexed (1)
Eli Lilly and Company (1) · Gynecologic Oncology Group (1)
United States (2) · Canada (1)
David Miller, MD (1) · Raymond Osborne (1)
U10CA027469 (1), U10CA180868 (1)